Articles related to Family Medicine/General Practice

“There is enormous exuberance about starting GLP-1 drugs, but not nearly enough attention to what happens when people stop.” – Senior study author Ziyad Al-Aly, MD; Washington University School of Medicine

The FDA notice added that a letter was sent out about the recall. However, it did not include a press release or other specific details.

“There is growing reason to believe [puberty blockers] are exacerbating the very dysphoria they are supposed to resolve and placing vulnerable children on a largely self-reinforcing path toward permanent transitions, often with serious and lasting physical consequences.” – Dr. Julia Mason

“Hidradenitis suppurativa (HS) affects far more than skin; it impacts confidence, emotional well-being and relationships during a formative period for many pediatric patients.” – Brindley Brooks, Founder & CEO, HS Connect.

“ACP believes it is important for patients and clinicians to have robust vaccine recommendations based on science rather than politics.” — Goldman, Mitchell & Hopkins, Annals of Internal Medicine

The approval was based on data from the randomized, double-blinded, parallel-group phase 3b STEP UP trial, which enrolled 1407 adults aged 18 years and older with a body mass index of at least 30kg/m2, without diabetes.